Macrophage Stimulation as a Useful Approach for Immunoscreening of Potential Vaccine Candidates Against Toxoplasma gondii and Neospora caninum Infections
- 24 November 2021
- book chapter
- Published by Springer Nature
- Vol. 2411, 129-144
Abstract
Toxoplasmosis and neosporosis are protozoan diseases that adversely affect the medical and additionally veterinary sectors, respectively. Toxoplasmosis is caused by Toxoplasma gondii which infects almost all warm-blooded animals including humans. While, neosporosis is caused by Neospora caninum, which induces infection in many animal species particularly in cattle. Currently, control measures for both infections are defective because of no effective vaccine or treatment. Macrophages constitute the first line of innate immunity, which contributes to the effective elimination of T. gondii or N. caninum. This action is mediated by IL-12, which is critical for the secretion of interferon gamma (IFN-γ). Successful vaccine candidates against both protozoan parasites should possess the ability to induce the cellular immune response and IFN-γ production. In this chapter, we will focus on an efficient immunological approach for discovery of potential vaccine candidates against above-mentioned parasites. Our previous studies revealed a strong correlation between vaccine antigens that enhanced the macrophage secretion of IL-12 and their efficacy as potential vaccine candidates in murine model. In case of T. gondii, peroxiredoxin 1 (TgPrx1) and peroxiredoxin 3 stimulated the production of IL-12 from murine peritoneal macrophages and conferred strong to moderate protection in C57BL/6 mice, respectively. At the same context, Neospora antigens of dense granule protein 6 (NcGRA6) and cyclophilin entrapped with oligo-mannose coated-liposomes stimulated macrophage IL-12 secretion and substantially protected immunized BALB/c mice. Therefore, we can deduce that macrophage stimulation evidenced in IL-12 production can be used as a useful approach for judgment of vaccine efficacy before further evaluation using in vivo experiments. Methods of vaccine preparation and macrophage stimulation will be fully described for TgPrx1 and NcGRA6 as potential vaccine candidates against toxoplasmosis and neosporosis, respectively.Keywords
This publication has 14 references indexed in Scilit:
- Neospora caninum in non-pregnant and pregnant mouse models: cross-talk between infection and immunityInternational Journal for Parasitology, 2017
- Immunization with Toxoplasma gondii peroxiredoxin 1 induces protective immunity against toxoplasmosis in micePLOS ONE, 2017
- Towards a preventive strategy for neosporosis: challenges and future perspectives for vaccine development against infection with Neospora caninumJournal of Veterinary Medical Science, 2017
- Peroxiredoxin 3 promotes IL-12 production from macrophages and partially protects mice against infection with Toxoplasma gondiiParasitology International, 2016
- Towards a Preventive Strategy for Toxoplasmosis: Current Trends, Challenges, and Future Perspectives for Vaccine Development2016
- Co-existence of classical and alternative activation programs in macrophages responding to Toxoplasma gondiiInternational Journal for Parasitology, 2014
- General strategies for efficient adjuvant incorporation of recombinant subunit immunogensVaccine, 2005
- Review of Neospora caninum and neosporosis in animalsThe Korean Journal of Parasitology, 2003
- Toxoplasma gondii: transmission, diagnosis and preventionClinical Microbiology and Infection, 2002
- Advances and prospects for subunit vaccines against protozoa of veterinary importanceVeterinary Parasitology, 2001